Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

COVID-19: Are Monoclonal Antibodies What the CLL Community Has Been Waiting For?

Recorded Thursday, December 2, 2021


While vaccines may be the best solution to the COVID-19 pandemic for the majority, CLL patients need an additional solution as vaccine response is variable and often impaired. Learn about monoclonal antibodies (mAbs) directed against the virus that causes COVID-19, which may be our best answer from Dr. Shahzad Mustafa, an immunology expert, and CLL Society’s own Dr. Brian Koffman and Robyn Brumble, RN.

This program was made possible by grant support from Adaptive Biotechnologies, Bristol Myers Squibb, Pharmacyclics, Janssen, and Regeneron.